Geoffrey Kelly

3PUBLICATIONS
74CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Jun 27, 2024
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma.

Edgar Gonzalez-Kozlova, Hsin-Hui Huang, Opeyemi A Jagede

|Mar 08, 2024
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.

Chang Gon Kim, Min Hee Hong, Dahee Kim

Pageof 1

Frequent Collaborators

3 joint publications

Seunghee Kim-Schulze

2 joint publications

Hui Xie

2 joint publications

Kai Nie

2 joint publications

Diane M Del Valle